CA 125 levels in endometriosis patients before, during and after treatment with Danazol or LHRH agonists
- 31 August 1989
- journal article
- research article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 32 (3) , 241-246
- https://doi.org/10.1016/0028-2243(89)90042-7
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Serum CA-125 in the evaluation of benign adnexal cystsAmerican Journal of Obstetrics and Gynecology, 1987
- Serum CA-125 antigen levels increase during mensesAmerican Journal of Obstetrics and Gynecology, 1987
- CA 125 Antigen Is an Effective Diagnostic for External EndometriosisGynecologic and Obstetric Investigation, 1987
- The use of CA-125 in the diagnosis and management of endometriosisFertility and Sterility, 1986
- CA 125: A useful marker in endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1986
- CA 125 antigen in human amniotic fluid and fetal membranesAmerican Journal of Obstetrics and Gynecology, 1986
- CA-125 levels in endometriosisFertility and Sterility, 1986
- Elevated serum concentrations of CA-125 in patients with advanced endometriosisFertility and Sterility, 1986
- Revised American Fertility Society Classification of Endometriosis: 1985Fertility and Sterility, 1985
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981